A comparison of patch angioplasty and stenting for axillary venous stenoses of thrombosed hemodialysis grafts.
The efficacy of balloon angioplasty with stent placement is compared to surgical patch angioplasty for thrombosed upper arm hemodialysis grafts with stenotic lesions at the venous anastomosis. Patients with thrombosed hemodialysis grafts terminating at the axillary vein were reviewed. Thirty-eight stents were placed after thrombectomy and venous balloon angioplasty in 26 patients. Fifteen case-matched controls underwent 23 polytetrafluoroethylene patch angioplasties for similar lesions. Kaplan-Meier survival analysis was used for statistical comparison. Primary patency for stent placement compared with patch angioplasty was not statistically different at any time through 1-year follow-up (37% vs 55% at 3 months, 25% vs 45% at 6 months, and 25% vs 15% at 12 months, respectively; p = 0.37). Secondary patency rates were slightly better for patch angioplasty compared with stent placement (78% vs 59% at 3 months, 78% vs 48% at 6 months, and 54% vs 32% at 12 months, respectively) however these differences were not statistically significant (p = 0.13). There was no difference in complication rates between groups. Sustained patency is poor for both angioplasty with stent placement and surgical patch angioplasty when revising thrombosed dialysis grafts with anastomotic axillary vein stenosis. These data suggest slightly better patency for the routine use of patch angioplasty for these lesions. However, the endovascular approach appears to be a reasonable alternative when surgical exposure is difficult.
Lombardi
Joseph V
JV
Section on Vascular Surgery, Pennsylvania Hospital, Philadelphia, PA, USA. Doclom@hotmail.com
Dougherty
Matthew J
MJ
Veitia
Nestor
N
Somal
Jack
J
Calligaro
Keith D
KD
D000368:Aged; D017130:Angioplasty; D001166:Arteriovenous Shunt, Surgical; D001365:Axilla; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D015993:Life Tables; D008297:Male; D011138:Polytetrafluoroethylene; D015607:Stents; D016896:Treatment Outcome
D011138:Polytetrafluoroethylene